Progyny, Inc. Selling Season Pacing to Record Level, Revealing Critical Insights on Latest Market Dynamics
Globe Newswire•07/10/2026•08:28 ET
0
Key Highlights
- ➤1.2 million new covered lives expected from commitments and anticipated decisions
- ➤Progyny’s 2027 selling season pacing toward a potential record for new managed-fertility lives
- ➤Employers are evaluating Progyny amid expected record increases in overall medical-plan costs
- ➤Progyny says its fertility program lowers costly complication risks while improving treatment effectiveness
Expert Statements
Pete Anevski, Chief Executive Officer, Progyny
“With the commitments we have received to date and anticipated remaining decisions, our selling season is pacing to a potential record level for new lives added for our managed fertility solution.”
Pete Anevski, Chief Executive Officer, Progyny
“We believe it isn’t coincidental that we’re seeing these strong results given the expected record increases in the overall medical plan cost in 2027.”
Pete Anevski, Chief Executive Officer, Progyny
“For those employers actively looking for ways to maintain or expand the family building services they are providing to their workforce in 2027, and who recognize the importance of doing so in a fiscally responsible way, Progyny’s standard practice includes an accelerated contracting path when working through one of our many channel partners and our best-in-class implementation timetable.”
Expecting 1.2 Million New Covered Lives from Commitments to Date and Anticipated Remaining Decisions
Reflects How Employers are Increasingly Turning to Solutions with a Proven Track Record of Delivering Savings, Total Cost Management and ROI
Get started
Create a free account to read the full story.